Wealth Effects »

Autolus Therapeutics Plc spon ads shares owned by Wealth Effects

Quarter-by-quarter ownership of Autolus Therapeutics Plc spon ads (AUTL) shares owned by Wealth Effects from 13F filings

Historical chart of Wealth Effects investment in Autolus Therapeutics Plc spon ads

Tip: Access up to 7 years of quarterly data

All positions including Autolus Therapeutics Plc spon ads held by Wealth Effects consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Autolus Therapeutics Plc spon ads by Wealth Effects

Quarter filed Position value Share count Share price at filing
2024-03-31 $262k 41k 6.38
2023-12-31 $277k 43k 6.44
2023-09-30 $110k 47k 2.33
2023-06-30 $112k 47k 2.38
2023-03-31 $83k 45k 1.84
2022-12-31 $80k 42k 1.90
2022-09-30 $93k 44k 2.13
2022-06-30 $108k 38k 2.83
2022-03-31 $132k 32k 4.17
2021-12-31 $119k 23k 5.19

More positions owned by Wealth Effects

Avadel Pharmaceuticals Sponsored Adr (AVDL)
NVIDIA Corporation (NVDA)
Apple (AAPL)
Amazon (AMZN)
Microsoft Corporation (MSFT)
Vanguard Index Fds Total Stk Mkt (VTI)
JPMorgan Chase & Co. (JPM)
Meta Platforms Cl A (META)
Alphabet Cap Stk Cl A (GOOGL)
The Trade Desk Com Cl A (TTD)
Arrowhead Pharmaceuticals (ARWR)
Blackstone Group Inc Com Cl A (BX)
Ishares Tr Core S&p500 Etf (IVV)
International Business Machines (IBM)
Chevron Corporation (CVX)

View all positions for Wealth Effects

Top funds holding Autolus Therapeutics Plc spon ads

Syncona Portfolio
Blackstone Group
Paradigm Biocapital Advisors
Polygon Management
Cormorant Asset Management
Frazier Life Sciences Management
T. Rowe Price Associates
Perpetual
Lynx1 Capital Management
Perceptive Advisors
Bank of New York Mellon
Fred Alger Management
Laurion Capital Management
Walleye Trading Advisors
Alphabet

View all funds holding Autolus Therapeutics Plc spon ads